Investing

SEC seeks more data to grant full market approval to Covaxin & Covishield


The Subject Expert Committee has also asked both companies to submit more data to study the vaccine’s efficacy and safety-related data thoroughly. The …

Read more at www.republicworld.com

Show More

Related Articles

Back to top button